DuoDERM® CGF® Border Dressing

• Promotes granulation and facilitates autolytic debridement
• Can be easily and gently molded into place
• Can be worn for up to seven days

DuoDERM® CGF® Border Dressing in indicated for use on: dermal ulcers, including full-thickness wounds, pressure ulcer management (stages 1-4), leg ulcer management, superficial wounds (e.g., minor abrasions), second-degree burns and donor sites

Contraindicated for use on individuals with a known sensitivity to the dressing or its components.

DuoDERM® CGF® Border Dressings are not recommended for use on third-degree burns.
When used on dermal ulcers:

1. Initial use of this product should be under the direction of a health professional.
2. DuoDERM® CGF® Border Dressings only provide local management of the wound site. In pressure injury care, other aspects such as repositioning of the patient and nutritional support should not be neglected. In leg ulcer care, lack of adequate rest in patients with vascular (arterial or venous) insufficiency can increase the amount of local edema and hinder potential healing.
3. Increased Wound Size: Deeper tissue damage may have already occurred under an apparent superficial dermal ulcer. When using any occlusive dressing in the presence of necrotic material, the wound may increase in size and depth during the initial phase of management as the necrotic debris is cleaned away. Leg ulcers resulting from vasculitis may rapidly deteriorate during exacerbation of the underlying disorder.

Odor: Wounds, particularly those that are large or necrotic, are often accompanied by a disagreeable odor; however, this is not necessarily indicative of infection. The odor should disappear when the wound is cleansed (see infection).

Infection: If signs of clinical infection should develop, such as: uncharacteristic odor or change in the color of the exudate, fever or cellulitis (tenderness and erythema in the area of the wound), a bacterial culture of the wound site should be taken. If clinical signs of infection are present, appropriate medical treatment should be initiated. DuoDERM® dressings may be continued during the treatment at the discretion of the clinician.

Granulation: Excessive granulation tissue may develop in some wounds when using occlusive dressings.